CUB STATEMENT ON PASSAGE OF BUDGET BILL
This federal legislation ramps up the importance of
These times call for strong consumer advocacy, and CUB is dedicated to working for consumer interests at the local, state, regional and federal levels as we fight for lower utility bills across
-
Background:
- The House of Representatives passed the budget reconciliation bill on
Thursday, July 3 , by a vote of 218-214. The bill passed the U.S. Senate on Tuesday. The vote was 50-50, with the Vice President breaking the tie. The federal legislation now heads to the President for signing. - Among other things, the bill ends these tax credits by Dec. 31, 2025:
- The "residential clean energy credit" helps consumers recoup up to 30 percent of the costs of energy-saving projects, like installing rooftop solar panels.
- The "energy efficient home improvement credit" helps people recoup up to 30 percent of the cost (up to
$1,200 /a year) for energy-saving projects, like a professional home energy audit; installing insulation; door, window and electric panel upgrades; and installing a high-efficiency air-conditioning unit. (There's an additional credit of up to$2,000 available for buying an electric heat pump or heat pump water heater.)
- Multiple studies have shown that rolling back clean energy tax credits could increase the average family's energy bill by hundreds of dollars within a decade. In
Illinois , the League of Conservation Voters has estimated that the legislation could lead to a$168 a year increase in residential energy bills, and a 21 percent increase in commercial and industrial energy bills.
For more than 40 years the Citizens Utility Board (CUB) has been
View original content to download multimedia:https://www.prnewswire.com/news-releases/cub-statement-on-passage-of-budget-bill-302498000.html
SOURCE Citizens Utility Board
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SAMARITAN'S PURSE EBOLA TREATMENT CENTERS OPEN IN THE EPICENTER OF THE DEADLY OUTBREAK
- IMA ART's Fertility Family Office - Swiss Governance for Family Continuity
- Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share